I became a GLP-1 'secret shopper' to see how easy it was to get a prescription. The results were alarming.

In the early 2020s, the blockbuster drug Ozempic (which had been FDA-approved for type 2 diabetes since 2018) became extremely difficult to get, as people clamored for effective weight loss options. The medication and its successors — Wegovy, Mounjaro and Zepbound — were expensive and so in demand that there was a shortage for the better part of three years, starting in March 2022.

Amid those shortages, telehealth providers started cropping up, offering something incredible: Prescriptions of GLP-1 weight loss drugs that you could get at a fraction of the price, without leaving the comfort of your home. Suddenly, the nearly impossible was easy. By November of 2025

Source: Yahoo Health →